Equity · Healthcare
PHR
Phreesia, Inc. · NYSE
The line runs $9 on 11 June through $10.70 on 17 July, on a scale from $8 to $12. Days the market did not trade hold the previous close, flat.
The chart above plots the price of PHR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 25 sessions over that window: $9 on 11 June 2026 through $10.70 on 17 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Sep 8, 2026
PHR insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 20 compensation filings in this window. The figures above count all of them.
PHR reported financials
PHR reported revenue of $467.8M for the fiscal year ended 31 Jan 2026. Net income over the same period was $2.3M.
Source: SEC EDGAR XBRL company facts · latest period ended 31 Jul 2026
PHR earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
PHR institutional holders
10 of the 45 institutional funds we track reported a PHR position for the quarter ended 30 Jun 2026 — a combined $58.7M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
PHR fails-to-deliver
On 11 Aug 2026, 31 shares of PHR failed to deliver (about $386) — the latest of 2 consecutive trading days with recorded fails.
Source: SEC fails-to-deliver (CNS) data
Congressional trades in PHR
The most recent congressional trade disclosed in PHR is a sale by Josh Gottheimer (house, NJ), dated 05 Mar 2026.
Source: U.S. House of Representatives financial disclosures